Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.900
+0.011 (1.28%)
At close: Mar 6, 2026, 4:00 PM EST
0.892
-0.008 (-0.87%)
After-hours: Mar 6, 2026, 8:00 PM EST
Oragenics Employees
Oragenics had 5 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,180,948
Market Cap
3.84M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 49 |
| HCW Biologics | 36 |
| Indaptus Therapeutics | 7 |
| Galmed Pharmaceuticals | 6 |
| Enveric Biosciences | 6 |
| GRI Bio | 4 |
| Acurx Pharmaceuticals | 4 |
| Matinas BioPharma Holdings | 3 |
OGEN News
- 26 days ago - Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy - GlobeNewsWire
- 4 weeks ago - Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program - GlobeNewsWire
- 4 months ago - Oragenics Q3 2025 Shareholder Update - Business Wire
- 4 months ago - Oragenics Regains Full NYSE American Compliance, Company Resolves Stockholder Equity Deficiency - Business Wire
- 5 months ago - Oragenics Announces Strategic Partnership with Receptor.AI to Accelerate Pipeline Development - Business Wire
- 7 months ago - Oragenics Q2 2025 Shareholder Update - GlobeNewsWire
- 8 months ago - Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development - GlobeNewsWire
- 8 months ago - Oragenics Completes Approximately $16.5 Million Offering - GlobeNewsWire